rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
18
|
pubmed:dateCreated |
2007-11-20
|
pubmed:abstractText |
Adequate antiretroviral exposure during pregnancy is critical to prevent the vertical transmission of HIV and for maternal health. Pregnancy can alter drug kinetics. We assessed the pharmacokinetics of atazanavir/ritonavir (300/100 mg a day) during pregnancy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1473-5571
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
30
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2409-15
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18025877-Adult,
pubmed-meshheading:18025877-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18025877-Chromatography, High Pressure Liquid,
pubmed-meshheading:18025877-Drug Administration Schedule,
pubmed-meshheading:18025877-Drug Monitoring,
pubmed-meshheading:18025877-Female,
pubmed-meshheading:18025877-Fetal Blood,
pubmed-meshheading:18025877-HIV Infections,
pubmed-meshheading:18025877-HIV Protease Inhibitors,
pubmed-meshheading:18025877-Humans,
pubmed-meshheading:18025877-Infant, Newborn,
pubmed-meshheading:18025877-Infectious Disease Transmission, Vertical,
pubmed-meshheading:18025877-Male,
pubmed-meshheading:18025877-Maternal-Fetal Exchange,
pubmed-meshheading:18025877-Oligopeptides,
pubmed-meshheading:18025877-Pregnancy,
pubmed-meshheading:18025877-Pregnancy Complications, Infectious,
pubmed-meshheading:18025877-Pregnancy Outcome,
pubmed-meshheading:18025877-Pyridines,
pubmed-meshheading:18025877-Ritonavir
|
pubmed:year |
2007
|
pubmed:articleTitle |
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.
|
pubmed:affiliation |
Division of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|